Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly. Clinical hallmarks of AMD are observed in one third of the elderly in industrialized countries. Preventative interventions through dietary modification are attractive strategies, because they are more affordable than clinical therapies, do not require specialists for administration and many studies suggest a benefit of micro- and macro-nutrients with respect to AMD with few, if any, adverse effects. The goal of this review is to provide information from recent literature on the value of various nutrients, particularly omega-3 fatty acids, lower glycemic index diets and, perhaps, some carotenoids, with regard to diminishing risk for onset or progression of AMD. Results from the upcoming Age-Related Eye Disease Study (AREDS) II intervention trial should be particularly informative.
Biarnes, M.; Mones, J.; Alonso, J.; Arias, L. Update on geographic atrophy in age-related macular degeneration. Optom. Vis. Sci. 2011, 88, 881–889, doi:10.1097/OPX.0b013e31821988c1.
[3]
Klein, R.; Cruickshanks, K.J.; Nash, S.D.; Krantz, E.M.; Javier Nieto, F.; Huang, G.H.; Pankow, J.S.; Klein, B.E. The prevalence of age-related macular degeneration and associated risk factors. Arch. Ophthalmol. 2010, 128, 750–758.
[4]
The Bright Focus Foundation. Facts on Macular Degeneration, Macular Degeneration Research. 2012. Available online: http://www.brightfocus.org/macular/about/understanding/facts.html. (accessed on 31 January 2013).
[5]
National Eye Institute, N.I.H. Facts about Age-Related Macular Degeneration; National Eye Institute: Bethesda, MD, USA, 2010.
[6]
Zarbin, M.A. Age-related macular degeneration: Review of pathogenesis. Eur. J. Ophthalmol. 1998, 8, 199–206.
[7]
Sung, C.H.; Chuang, J.Z. The cell biology of vision. J. Cell Biol. 2010, 190, 953–963, doi:10.1083/jcb.201006020.
[8]
Sivaprasad, S.; Bailey, T.A.; Chong, V.N. Bruch’s membrane and the vascular intima: Is there a common basis for age-related changes and disease? Clin. Exp. Ophthalmol. 2005, 33, 518–523, doi:10.1111/j.1442-9071.2005.01074.x.
[9]
Shakib, M.; Zinn, K.M. Fine structure and function of ocular tissues. The choroid, bruch’s membrane, and the retinal pigment epithelium. Int. Ophthalmol. Clin. 1973, 13, 189–204.
[10]
Curcio, C.A.; Millican, C.L. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 1999, 117, 329–339, doi:10.1001/archopht.117.3.329.
[11]
Ding, X.; Patel, M.; Chan, C.C. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res. 2009, 28, 1–18, doi:10.1016/j.preteyeres.2008.10.001.
[12]
Jager, R.D.; Mieler, W.F.; Miller, J.W. Age-related macular degeneration. N. Engl. J. Med. 2008, 358, 2606–2617, doi:10.1056/NEJMra0801537.
[13]
Al-Hussaini, H.; Schneiders, M.; Lundh, P.; Jeffery, G. Drusen are associated with local and distant disruptions to human retinal pigment epithelium cells. Exp. Eye Res. 2009, 88, 610–612, doi:10.1016/j.exer.2008.09.021.
[14]
Wang, A.L.; Lukas, T.J.; Yuan, M.; Du, N.; Tso, M.O.; Neufeld, A.H. Autophagy and exosomes in the aged retinal pigment epithelium: Possible relevance to drusen formation and age-related macular degeneration. PLoS One 2009, 4, e4160.
The Age-Related Eye Disease Study Research Group. The age-related eye disease study (areds) system for classifying cataracts from photographs: AREDS Report No. 4. Am. J. Ophthalmol. 2001, 131, 167–175.
[17]
Friedman, D.S.; O’Colmain, B.J.; Munoz, B.; Tomany, S.C.; McCarty, C.; de Jong, P.T.; Nemesure, B.; Mitchell, P.; Kempen, J.; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the united states. Arch. Ophthalmol. 2004, 122, 564–572.
[18]
Hageman, G.S.; Anderson, D.H.; Johnson, L.V.; Hancox, L.S.; Taiber, A.J.; Hardisty, L.I.; Hageman, J.L.; Stockman, H.A.; Borchardt, J.D.; Gehrs, K.M.; et al. A common haplotype in the complement regulatory gene factor h (hf1/cfh) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2005, 102, 7227–7232, doi:10.1073/pnas.0501536102.
[19]
Edwards, A.O.; Ritter, R., III; Abel, K.J.; Manning, A.; Panhuysen, C.; Farrer, L.A. Complement factor h polymorphism and age-related macular degeneration. Science 2005, 308, 421–424.
[20]
Haines, J.L.; Hauser, M.A.; Schmidt, S.; Scott, W.K.; Olson, L.M.; Gallins, P.; Spencer, K.L.; Kwan, S.Y.; Noureddine, M.; Gilbert, J.R.; et al. Complement factor h variant increases the risk of age-related macular degeneration. Science 2005, 308, 419–421, doi:10.1126/science.1110359.
Peeters, A.; Magliano, D.J.; Stevens, J.; Duncan, B.B.; Klein, R.; Wong, T.Y. Changes in abdominal obesity and age-related macular degeneration: The atherosclerosis risk in communities study. Arch. Ophthalmol. 2008, 126, 1554–1560, doi:10.1001/archopht.126.11.1554.
[24]
Smiddy, W.E.; Fine, S.L. Prognosis of patients with bilateral macular drusen. Ophthalmology 1984, 91, 271–277.
[25]
Weikel, K.A.; Chiu, C.J.; Taylor, A. Nutritional modulation of age-related macular degeneration. Mol. Aspects Med. 2012, 33, 318–375, doi:10.1016/j.mam.2012.03.005.
[26]
Jenkins, D.J.; Wolever, T.M.; Taylor, R.H.; Barker, H.; Fielden, H.; Baldwin, J.M.; Bowling, A.C.; Newman, H.C.; Jenkins, A.L.; Goff, D.V. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am. J. Clin. Nutr. 1981, 34, 362–366.
[27]
Chiu, C.J.; Taylor, A. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog. Retin. Eye Res. 2011, 30, 18–53, doi:10.1016/j.preteyeres.2010.09.001.
[28]
Chiu, C.-J.; Liu, S.; Willett, W.C.; Wolever, T.M.S.; Brand-Miller, J.C.; Barclay, A.C.; Taylor, A. Informing food choices and health outcomes by use of the dietary glycemic index. Nutr. Rev. 2011, 69, 231–242, doi:10.1111/j.1753-4887.2011.00382.x.
[29]
Chiu, C.J.; Milton, R.C.; Gensler, G.; Taylor, A. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the age-related eye disease study. Am. J. Clin. Nutr. 2007, 86, 180–188.
[30]
Chiu, C.J.; Hubbard, L.D.; Armstrong, J.; Rogers, G.; Jacques, P.F.; Chylack, L.T., Jr.; Hankinson, S.E.; Willett, W.C.; Taylor, A. Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration. Am. J. Clin. Nutr. 2006, 83, 880–886.
[31]
Chiu, C.J.; Milton, R.C.; Klein, R.; Gensler, G.; Taylor, A. Dietary carbohydrate and the progression of age-related macular degeneration: A prospective study from the age-related eye disease study. Am. J. Clin. Nutr. 2007, 86, 1210–1218.
[32]
Chiu, C.J.; Klein, R.; Milton, R.C.; Gensler, G.; Taylor, A. Does eating particular diets alter risk of age-related macular degeneration in users of the age-related eye disease study supplements? Br. J. Ophthalmol. 2009, 93, 1241–1246, doi:10.1136/bjo.2008.143412.
[33]
Kaushik, S.; Wang, J.J.; Flood, V.; Tan, J.S.; Barclay, A.W.; Wong, T.Y.; Brand-Miller, J.; Mitchell, P. Dietary glycemic index and the risk of age-related macular degeneration. Am. J. Clin. Nutr. 2008, 88, 1104–1110.
[34]
Weikel, K.A.; Fitzgerald, P.; Shang, F.; Caceres, M.A.; Bian, Q.; Handa, J.T.; Stitt, A.W.; Taylor, A. Natural history of age-related retinal lesions that precede amd in mice fed high or low glycemic index diets. Investig. Ophthalmol. Vis. Sci. 2012, 53, 622–632, doi:10.1167/iovs.11-8545.
[35]
Uchiki, T.; Weikel, K.A.; Jiao, W.; Shang, F.; Caceres, A.; Pawlak, D.B.; Handa, J.T.; Brownlee, M.; Nagaraj, R.; Taylor, A. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in non diabetics). Aging Cell 2012, 11, 1–13, doi:10.1111/j.1474-9726.2011.00752.x.
[36]
Ludwig, D.S. The glycemic index: Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002, 287, 2414–2423, doi:10.1001/jama.287.18.2414.
[37]
Brand-Miller, J.C.; Holt, S.H.; Pawlak, D.B.; McMillan, J. Glycemic index and obesity. Am. J. Clin. Nutr. 2002, 76, 281S–285S.
[38]
Schweigert, F.J.; Reimann, J. Micronutrients and their relevance for the eye—Function of lutein, zeaxanthin and omega-3 fatty acids. Klin. Monbl. Augenheilkd. 2011, 228, 537–543, doi:10.1055/s-0029-1245527.
Seddon, J.M.; Rosner, B.; Sperduto, R.D.; Yannuzzi, L.; Haller, J.A.; Blair, N.P.; Willett, W. Dietary fat and risk for advanced age-related macular degeneration. Arch. Ophthalmol. 2001, 119, 1191–1199, doi:10.1001/archopht.119.8.1191.
[41]
Seddon, J.M.; George, S.; Rosner, B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: The us twin study of age-related macular degeneration. Arch. Ophthalmol. 2006, 124, 995–1001, doi:10.1001/archopht.124.7.995.
[42]
SanGiovanni, J.P.; Chew, E.Y.; Clemons, T.E.; Davis, M.D.; Ferris, F.L., III; Gensler, G.R.; Kurinij, N.; Lindblad, A.S.; Milton, R.C.; Seddon, J.M.; et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: Areds report no. 20. Arch. Ophthalmol. 2007, 125, 671–679.
[43]
Christen, W.G.; Schaumberg, D.A.; Glynn, R.J.; Buring, J.E. Dietary omega-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch. Ophthalmol. 2011, 129, 921–929, doi:10.1001/archophthalmol.2011.34.
[44]
Cho, E.; Hung, S.; Willett, W.C.; Spiegelman, D.; Rimm, E.B.; Seddon, J.M.; Colditz, G.A.; Hankinson, S.E. Prospective study of dietary fat and the risk of age-related macular degeneration. Am. J. Clin. Nutr. 2001, 73, 209–218.
[45]
Chong, E.W.; Robman, L.D.; Simpson, J.A.; Hodge, A.M.; Aung, K.Z.; Dolphin, T.K.; English, D.R.; Giles, G.G.; Guymer, R.H. Fat consumption and its association with age-related macular degeneration. Arch. Ophthalmol. 2009, 127, 674–680, doi:10.1001/archophthalmol.2009.60.
[46]
Tan, J.S.; Wang, J.J.; Flood, V.; Mitchell, P. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: The blue mountains eye study. Arch. Ophthalmol. 2009, 127, 656–665, doi:10.1001/archophthalmol.2009.76.
[47]
Chua, B.; Flood, V.; Rochtchina, E.; Wang, J.J.; Smith, W.; Mitchell, P. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch. Ophthalmol. 2006, 124, 981–986, doi:10.1001/archopht.124.7.981.
[48]
Augood, C.; Chakravarthy, U.; Young, I.; Vioque, J.; de Jong, P.T.; Bentham, G.; Rahu, M.; Seland, J.; Soubrane, G.; Tomazzoli, L.; et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am. J. Clin. Nutr. 2008, 88, 398–406.
[49]
Johnson, E.J.; Chung, H.Y.; Caldarella, S.M.; Snodderly, D.M. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am. J. Clin. Nutr. 2008, 87, 1521–1529.
[50]
Souied, E.H.; Delcourt, C.; Querques, G.; Bassols, A.; Merle, B.; Zourdani, A.; Smith, T.; Benlian, P. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: The nutritional amd treatment 2 study. Ophthalmology 2013, 7, 7–9.
[51]
Mance, T.C.; Kovacevic, D.; Alpeza-Dunato, Z.; Stroligo, M.N.; Brumini, G. The role of omega6 to omega3 ratio in development and progression of age-related macular degeneration. Coll. Antropol. 2011, 2, 307–310.
[52]
Chiu, C.J.; Milton, R.C.; Klein, R.; Gensler, G.; Taylor, A. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology 2009, 116, 939–946, doi:10.1016/j.ophtha.2008.12.025.
Parekh, N.; Voland, R.P.; Moeller, S.M.; Blodi, B.A.; Ritenbaugh, C.; Chappell, R.J.; Wallace, R.B.; Mares, J.A. Association between dietary fat intake and age-related macular degeneration in the carotenoids in age-related eye disease study (careds): An ancillary study of the women’s health initiative. Arch. Ophthalmol. 2009, 127, 1483–1493, doi:10.1001/archophthalmol.2009.130.
[55]
Robman, L.; Vu, H.; Hodge, A.; Tikellis, G.; Dimitrov, P.; McCarty, C.; Guymer, R. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can. J. Ophthalmol. 2007, 42, 720–726, doi:10.3129/i07-116.
[56]
Meyer, B.J.; Mann, N.J.; Lewis, J.L.; Milligan, G.C.; Sinclair, A.J.; Howe, P.R. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38, 391–398, doi:10.1007/s11745-003-1074-0.
[57]
Seddon, J.M.; Cote, J.; Rosner, B. Progression of age-related macular degeneration: Association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol. 2003, 121, 1728–1737, doi:10.1001/archopht.121.12.1728.
[58]
Smith, W.; Mitchell, P.; Leeder, S.R. Dietary fat and fish intake and age-related maculopathy. Arch. Ophthalmol. 2000, 118, 401–404, doi:10.1001/archopht.118.3.401.
[59]
Swenor, B.K.; Bressler, S.; Caulfield, L.; West, S.K. The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology 2010, 117, 2395–2401, doi:10.1016/j.ophtha.2010.03.058.
[60]
Delcourt, C.; Carriere, I.; Cristol, J.P.; Lacroux, A.; Gerber, M. Dietary fat and the risk of age-related maculopathy: The polanut study. Eur. J. Clin. Nutr. 2007, 61, 1341–1344, doi:10.1038/sj.ejcn.1602685.
[61]
Heuberger, R.A.; Mares-Perlman, J.A.; Klein, R.; Klein, B.E.; Millen, A.E.; Palta, M. Relationship of dietary fat to age-related maculopathy in the third national health and nutrition examination survey. Arch. Ophthalmol. 2001, 119, 1833–1838, doi:10.1001/archopht.119.12.1833.
[62]
Granado, F.; Olmedilla, B.; Blanco, I. Nutritional and clinical relevance of lutein in human health. Br. J. Nutr. 2003, 90, 487–502, doi:10.1079/BJN2003927.
[63]
Dietzel, M.; Zeimer, M.; Heimes, B.; Claes, B.; Pauleikhoff, D.; Hense, H.W. Determinants of macular pigment optical density and its relation to age-related maculopathy: Results from the muenster aging and retina study (mars). Investig. Ophthalmol. Vis. Sci. 2011, 52, 3452–3457, doi:10.1167/iovs.10-6713.
[64]
Schalch, W.; Cohn, W.; Barker, F.M.; Kopcke, W.; Mellerio, J.; Bird, A.C.; Robson, A.G.; Fitzke, F.F.; van Kuijk, F.J. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin—The luxea (lutein xanthophyll eye accumulation) study. Arch. Biochem. Biophys. 2007, 458, 128–135, doi:10.1016/j.abb.2006.09.032.
[65]
Landrum, J.T.; Bone, R.A.; Joa, H.; Kilburn, M.D.; Moore, L.L.; Sprague, K.E. A one year study of the macular pigment: The effect of 140 days of a lutein supplement. Exp. Eye Res. 1997, 65, 57–62, doi:10.1006/exer.1997.0309.
Ma, L.; Dou, H.-L.; Wu, Y.-Q.; Huang, Y.-M.; Huang, Y.-B.; Xu, X.-R.; Zou, Z.-Y.; Lin, X.-M. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: A systematic review and meta-analysis. Br. J. Nutr. 2012, 107, 350–359, doi:10.1017/S0007114511004260.
[68]
SanGiovanni, J.P.; Neuringer, M. The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: Promise of molecular genetics for guiding mechanistic and translational research in the field. Am. J. Clin. Nutr. 2012, 96, 10.
[69]
Seddon, J.M.; Ajani, U.A.; Sperduto, R.D.; Hiller, R.; Blair, N.; Burton, T.C.; Farber, M.D.; Gragoudas, E.S.; Haller, J.; Miller, D.T.; et al. Dietary carotenoids, vitamins a, c, and e, and advanced age-related macular degeneration. Eye disease case-control study group. JAMA 1994, 272, 1413–1420.
[70]
Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch. Ophthalmol. 1993, 111, 104–109.
[71]
Snellen, E.L.; Verbeek, A.L.; van den Hoogen, G.W.; Cruysberg, J.R.; Hoyng, C.B. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol. Scand. 2002, 80, 368–371, doi:10.1034/j.1600-0420.2002.800404.x.
[72]
Gale, C.R.; Hall, N.F.; Phillips, D.I.W.; Martyn, C.N. Lutein and zeaxanthin status and risk of age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2003, 44, 2461–2465, doi:10.1167/iovs.02-0929.
[73]
Delcourt, C.; Carriere, I.; Delage, M.; Barberger-Gateau, P.; Schalch, W. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: The pola study. Investig. Ophthalmol. Vis. Sci. 2006, 47, 2329–2335, doi:10.1167/iovs.05-1235.
[74]
Mares-Perlman, J.A.; Fisher, A.I.; Klein, R.; Palta, M.; Block, G.; Millen, A.E.; Wright, J.D. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am. J. Epidemiol. 2001, 153, 424–432, doi:10.1093/aje/153.5.424.
Zeimer, M.; Hense, H.W.; Heimes, B.; Austermann, U.; Fobker, M.; Pauleikhoff, D. The macular pigment: Short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The luna study. Ophthalmologe 2009, 106, 29–36, doi:10.1007/s00347-008-1773-4.
[77]
Bone, R.A.; Landrum, J.T. Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters. Arch. Biochem. Biophys. 2010, 504, 50–55, doi:10.1016/j.abb.2010.06.019.
[78]
Loughman, J.; Nolan, J.M.; Howard, A.N.; Connolly, E.; Meagher, K.; Beatty, S. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Investig. Ophthalmol. Vis. Sci. 2012, 53, 7871–7880, doi:10.1167/iovs.12-10690.
[79]
Ma, L.; Yan, S.F.; Huang, Y.M.; Lu, X.R.; Qian, F.; Pang, H.L.; Xu, X.R.; Zou, Z.Y.; Dong, P.C.; Xiao, X.; et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology 2012, 119, 2290–2297, doi:10.1016/j.ophtha.2012.06.014.
[80]
Richer, S.P.; Stiles, W.; Graham-Hoffman, K.; Levin, M.; Ruskin, D.; Wrobel, J.; Park, D.W.; Thomas, C. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: The zeaxanthin and visual function study (zvf) fda ind #78, 973. Optometry 2011, 82, 667–680, doi:10.1016/j.optm.2011.08.008.
[81]
Piermarocchi, S.; Saviano, S.; Parisi, V.; Tedeschi, M.; Panozzo, G.; Scarpa, G.; Boschi, G.; Lo Giudice, G. Carotenoids in age-related maculopathy italian study (CARMIS): Two-year results of a randomized study. Eur. J. Ophthalmol. 2012, 22, 216–225, doi:10.5301/ejo.5000069.
[82]
Richer, S.; Stiles, W.; Statkute, L.; Pulido, J.; Frankowski, J.; Rudy, D.; Pei, K.; Tsipursky, M.; Nyland, J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: The veterans last study (lutein antioxidant supplementation trial). Optometry 2004, 75, 216–230, doi:10.1016/S1529-1839(04)70049-4.
[83]
Richer, S.; Devenport, J.; Lang, J.C. Last ii: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry 2007, 78, 213–219, doi:10.1016/j.optm.2006.10.019.
[84]
Trieschmann, M.; Beatty, S.; Nolan, J.M.; Hense, H.W.; Heimes, B.; Austermann, U.; Fobker, M.; Pauleikhoff, D. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: The luna study. Exp. Eye Res. 2007, 84, 718–728, doi:10.1016/j.exer.2006.12.010.
[85]
Cardinault, N.; Abalain, J.H.; Sairafi, B.; Coudray, C.; Grolier, P.; Rambeau, M.; Carre, J.L.; Mazur, A.; Rock, E. Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clin. Chim. Acta 2005, 357, 34–42, doi:10.1016/j.cccn.2005.01.030.
[86]
Sanders, T.A.B.; Haines, A.P.; Wormald, R.; Wright, L.A.; Obeid, O. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am. J. Clin. Nutr. 1993, 57, 428–433.
[87]
Seddon, J.M.; Reynolds, R.; Rosner, B. Associations of smoking, body mass index, dietary lutein, and the lipc gene variant rs10468017 with advanced age-related macular degeneration. Mol. Vis. 2010, 16, 2412–2424.
[88]
Michikawa, T.; Ishida, S.; Nishiwaki, Y.; Kikuchi, Y.; Tsuboi, T.; Hosoda, K.; Ishigami, A.; Iwasawa, S.; Nakano, M.; Takebayashi, T. Serum antioxidants and age-related macular degeneration among older japanese. Asia Pac. J. Clin. Nutr. 2009, 18, 1–7.
[89]
Fletcher, A.E.; Bentham, G.C.; Agnew, M.; Young, I.S.; Augood, C.; Chakravarthy, U.; de Jong, P.T.; Rahu, M.; Seland, J.; Soubrane, G.; et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch. Ophthalmol. 2008, 126, 1396–1403, doi:10.1001/archopht.126.10.1396.
[90]
Mares-Perlman, J.; Klein, R.; Klein, B.E.K.; Greger, J.L.; Brady, W.E.; Palta, M.; Ritter, L.L. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch. Ophthalmol. 1996, 114, 991–997, doi:10.1001/archopht.1996.01100140199014.
[91]
Van Leeuwen, R.; Boekhoorn, S.; Vingerling, J.R.; Witteman, J.C.; Klaver, C.C.; Hofman, A.; de Jong, P.T. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005, 294, 3101–3107, doi:10.1001/jama.294.24.3101.
[92]
Flood, V.; Smith, W.; Wang, J.J.; Manzi, F.; Webb, K.; Mitchell, P. Dietary antioxidant intake and incidence of early age-related maculopathy: The blue mountains eye study. Ophthalmology 2002, 109, 2272–2278, doi:10.1016/S0161-6420(02)01263-0.
[93]
Tan, J.S.; Wang, J.J.; Flood, V.; Rochtchina, E.; Smith, W.; Mitchell, P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: The blue mountains eye study. Ophthalmology 2008, 115, 334–341, doi:10.1016/j.ophtha.2007.03.083.
[94]
VandenLangenberg, G.M.; Mares-Perlman, J.A.; Klein, R.; Klein, B.E.; Brady, W.E.; Palta, M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the beaver dam eye study. Am. J. Epidemiol. 1998, 148, 204–214, doi:10.1093/oxfordjournals.aje.a009625.
[95]
Cho, E.; Seddon, J.M.; Rosner, B.; Willett, W.C.; Hankinson, S.E. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch. Ophthalmol. 2004, 122, 883–892, doi:10.1001/archopht.122.6.883.
[96]
Cho, E.; Hankinson, S.E.; Rosner, B.; Willett, W.C.; Colditz, G.A. Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration. Am. J. Clin. Nutr. 2008, 87, 1837–1843.
[97]
Smith, W.; Mitchell, P.; Rochester, C. Serum beta carotene, alpha tocopherol, and age-related maculopathy: The blue mountains eye study. Am. J. Ophthalmol. 1997, 124, 838–840.
[98]
Mares-Perlman, J.A.; Brady, W.E.; Klein, R.; Klein, B.E.; Bowen, P.; Stacewicz-Sapuntzakis, M.; Palta, M. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch. Ophthalmol. 1995, 113, 1518–1523, doi:10.1001/archopht.1995.01100120048007.
[99]
San Giovanni, J.P.; Chew, E.Y.; Clemons, T.E.; Ferris, F.L., III; Gensler, G.; Lindblad, A.S.; Milton, R.C.; Seddon, J.M.; Sperduto, R.D. The relationship of dietary carotenoid and vitamin a, e, and c intake with age-related macular degeneration in a case-control study: Areds report no. 22. Arch. Ophthalmol. 2007, 125, 1225–1232.
[100]
West, S.; Vitale, S.; Hallfrisch, J.; Munoz, B.; Muller, D.; Bressler, S.; Bressler, N.M. Are antioxidants or supplements protective for age-related macular degeneration? Arch. Ophthalmol. 1994, 112, 222–227, doi:10.1001/archopht.1994.01090140098031.
[101]
Teikari, J.M.; Laatikainen, L.; Virtamo, J.; Haukka, J.; Rautalahti, M.; Liesto, K.; Albanes, D.; Taylor, P.; Heinonen, O.P. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol. Scand. 1998, 76, 224–229.
[102]
Morris, M.S.; Jacques, P.F.; Chylack, L.T.; Hankinson, S.E.; Willett, W.C.; Hubbard, L.D.; Taylor, A. Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions. Ophthalmic Epidemiol. 2007, 14, 288–298, doi:10.1080/09286580601186759.
[103]
Maiani, G.; Caston, M.J.; Catasta, G.; Toti, E.; Cambrodon, I.G.; Bysted, A.; Granado-Lorencio, F.; Olmedilla-Alonso, B.; Knuthsen, P.; Valoti, M.; et al. Carotenoids: Actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol. Nutr. Food Res. 2009, 53, S194–S218, doi:10.1002/mnfr.200800053.
[104]
Simonelli, F.; Zarrilli, F.; Mazzeo, S.; Verde, V.; Romano, N.; Savoia, M.; Testa, F.; Vitale, D.F.; Rinaldi, M.; Sacchetti, L. Serum oxidative and antioxidant parameters in a group of italian patients with age-related maculopathy. Clin. Chim. Acta 2002, 320, 111–115, doi:10.1016/S0009-8981(02)00056-6.
[105]
Obana, A.; Hiramitsu, T.; Gohto, Y.; Ohira, A.; Mizuno, S.; Hirano, T.; Bernstein, P.S.; Fujii, H.; Iseki, K.; Tanito, M.; et al. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a japanese population. Ophthalmology 2008, 115, 147–157, doi:10.1016/j.ophtha.2007.02.028.
[106]
Blumenkranz, M.S.; Russell, S.R.; Robey, M.G.; Kott-Blumenkranz, R.; Penneys, N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986, 93, 552–558.
[107]
Ishihara, N.; Yuzawa, M.; Tamakoshi, A. Antioxidants and angiogenetic factor associated with age-related macular degeneration (exudative type). Nippon Ganka Gakkai Zasshi 1997, 101, 248–251.
Klein, B.E.; Knudtson, M.D.; Lee, K.E.; Reinke, J.O.; Danforth, L.G.; Wealti, A.M.; Moore, E.; Klein, R. Supplements and age-related eye conditions the beaver dam eye study. Ophthalmology 2008, 115, 1203–1208, doi:10.1016/j.ophtha.2007.09.011.
[110]
Belda, J.I.; Roma, J.; Vilela, C.; Puertas, F.J.; Diaz-Llopis, M.; Bosch-Morell, F.; Romero, F.J. Serum vitamin e levels negatively correlate with severity of age-related macular degeneration. Mech. Ageing Dev. 1999, 107, 159–164, doi:10.1016/S0047-6374(98)00144-4.
[111]
Delcourt, C.; Cristol, J.P.; Tessier, F.; Leger, C.L.; Descomps, B.; Papoz, L. Age-related macular degeneration and antioxidant status in the pola study. Pola study group. Pathologies oculaires liees a l’age. Arch. Ophthalmol. 1999, 117, 1384–1390.
[112]
Shen, X.L.; Jia, J.H.; Zhao, P.; Fan, R.; Pan, X.Y.; Yang, H.M.; Liu, L. Changes in blood oxidative and antioxidant parameters in a group of chinese patients with age-related macular degeneration. J. Nutr. Health Aging 2012, 16, 201–204, doi:10.1007/s12603-011-0350-8.
[113]
Christen, W.G.; Ajani, U.A.; Glynn, R.J.; Manson, J.E.; Schaumberg, D.A.; Chew, E.C.; Buring, J.E.; Hennekens, C.H. Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am. J. Epidemiol. 1999, 149, 476–484, doi:10.1093/oxfordjournals.aje.a009836.
[114]
Christen, W.G.; Glynn, R.J.; Sesso, H.D.; Kurth, T.; MacFadyen, J.; Bubes, V.; Buring, J.E.; Manson, J.E.; Gaziano, J.M. Age-related cataract in a randomized trial of vitamins e and c in men. Arch. Ophthalmol. 2010, 128, 1397–1405, doi:10.1001/archophthalmol.2010.266.
Christen, W.G.; Glynn, R.J.; Sesso, H.D.; Kurth, T.; Macfadyen, J.; Bubes, V.; Buring, J.E.; Manson, J.E.; Gaziano, J.M. Vitamins e and c and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology 2012, 119, 1642–1649, doi:10.1016/j.ophtha.2012.01.053.
[117]
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e and beta carotene for age-related cataract and vision loss: Areds report no. 9. Arch. Ophthalmol. 2001, 119, 1439–1452.
[118]
Chew, E.Y.; Lindblad, A.S.; Clemons, T. Summary results and recommendations from the age-related eye disease study. Arch. Ophthalmol. 2009, 127, 1678–1679, doi:10.1001/archophthalmol.2009.312.
[119]
Parisi, V.; Tedeschi, M.; Gallinaro, G.; Varano, M.; Saviano, S.; Piermarocchi, S. Carotenoids and antioxidants in age-related maculopathy italian study: Multifocal electroretinogram modifications after 1 year. Ophthalmology 2008, 115, 324–333, doi:10.1016/j.ophtha.2007.05.029.
[120]
Richer, S. Multicenter ophthalmic and nutritional age-related macular degeneration study—Part 2: Antioxidant intervention and conclusions. J. Am. Optom. Assoc. 1996, 67, 30–49.
[121]
Cangemi, F.E. Tozal study: An open case control study of an oral antioxidant and omega-3 supplement for dry amd. BMC Ophthalmol. 2007, 7, 3, doi:10.1186/1471-2415-7-3.
[122]
Beatty, S.; Chakravarthy, U.; Nolan, J.M.; Muldrew, K.A.; Woodside, J.V.; Denny, F.; Stevenson, M.R. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology 2012, 120, 600–606.
[123]
Kuzniarz, M.; Mitchell, P.; Flood, V.M.; Wang, J.J. Use of vitamin and zinc supplements and age-related maculopathy: The blue mountains eye study. Ophthalmic Epidemiol. 2002, 9, 283–295, doi:10.1076/opep.9.4.283.1511.
[124]
Ho, L.; van Leeuwen, R.; Witteman, J.C.; van Duijn, C.M.; Uitterlinden, A.G.; Hofman, A.; de Jong, P.T.; Vingerling, J.R.; Klaver, C.C. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: The rotterdam study. Arch. Ophthalmol. 2011, 129, 758–766, doi:10.1001/archophthalmol.2011.141.
[125]
King, J.C. Zinc: An essential but elusive nutrient. Am. J. Clin. Nutr. 2011, 94, 679S–684S, doi:10.3945/ajcn.110.005744.
[126]
Erie, J.C.; Good, J.A.; Butz, J.A.; Pulido, J.S. Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration. Am. J. Ophthalmol. 2009, 147, 276–282, doi:10.1016/j.ajo.2008.08.014.
[127]
Newsome, D.A.; Swartz, M.; Leone, N.C.; Elston, R.C.; Miller, E. Oral zinc in macular degeneration. Arch. Ophthalmol. 1988, 106, 192–198, doi:10.1001/archopht.1988.01060130202026.
[128]
Yuzbasiyan-Gurkan, V.; Brewer, G.J. The therapeutic use of zinc in macular degeneration. Arch. Ophthalmol. 1989, 107, 1723–1724, doi:10.1001/archopht.1989.01070020805004.
Newsome, D.A. A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Curr. Eye Res. 2008, 33, 591–598, doi:10.1080/02713680802178437.
[131]
Smith, W.; Mitchell, P.; Webb, K.; Leeder, S.R. Dietary antioxidants and age-related maculopathy: The blue mountains eye study. Ophthalmology 1999, 106, 761–767, doi:10.1016/S0161-6420(99)90164-1.
[132]
Cho, E.; Stampfer, M.J.; Seddon, J.M.; Hung, S.; Spiegelman, D.; Rimm, E.B.; Willett, W.C.; Hankinson, S.E. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann. Epidemiol. 2001, 11, 328–336, doi:10.1016/S1047-2797(01)00217-4.
[133]
Stur, M.; Tittl, M.; Reitner, A.; Meisinger, V. Oral zinc and the second eye in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 1996, 37, 1225–1235.
[134]
Parekh, N.; Chappell, R.J.; Millen, A.E.; Albert, D.M.; Mares, J.A. Association between vitamin d and age-related macular degeneration in the third national health and nutrition examination survey, 1988 through 1994. Arch. Ophthalmol. 2007, 125, 661–669, doi:10.1001/archopht.125.5.661.
[135]
Millen, A.E.; Voland, R.; Sondel, S.A.; Parekh, N.; Horst, R.L.; Wallace, R.B.; Hageman, G.S.; Chappell, R.; Blodi, B.A.; Klein, M.L.; et al. Vitamin d status and early age-related macular degeneration in postmenopausal women. Arch. Ophthalmol. 2011, 129, 481–489, doi:10.1001/archophthalmol.2011.48.
